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in-hospital mortality from acute myocardial
infarction in Switzerland between 1998 and 2008
Charlène Insam1, Fred Paccaud1 and Pedro Marques-Vidal1,2*Abstract
Background: Since the late nineties, no study has assessed the trends in management and in-hospital outcome of
acute myocardial infarction (AMI) in Switzerland. Our objective was to fill this gap.
Methods: Swiss hospital discharge database for years 1998 to 2008. AMI was defined as a primary discharge
diagnosis code I21 according to the ICD10 classification. Invasive treatments and overall in-hospital mortality were
assessed.
Results: Overall, 102,729 hospital discharges with a diagnosis of AMI were analyzed. The percentage of
hospitalizations with a stay in an Intensive Care Unit decreased from 38.0% in 1998 to 36.2% in 2008
(p for trend < 0.001). Percutaneous revascularizations increased from 6.0% to 39.9% (p for trend < 0.001). Bare stents
rose from 1.3% to 16.6% (p for trend < 0.001). Drug eluting stents appeared in 2004 and increased to 23.5% in 2008
(p for trend < 0.001). Coronary artery bypass graft increased from 1.0% to 3.0% (p for trend < 0.001). Circulatory
assistance increased from 0.2% to 1.7% (p for trend < 0.001). Among patients managed in a single hospital (not
transferred), seven-day and total in-hospital mortality decreased from 8.0% to 7.0% (p for trend < 0.01) and from
11.2% to 10.1%, respectively. These changes were no longer significant after multivariate adjustment for age,
gender, region, revascularization procedures and transfer type. After multivariate adjustment, differing trends in
revascularization procedures and in in-hospital mortality were found according to the geographical region
considered.
Conclusion: In Switzerland, a steep rise in hospital discharges and in revascularization procedures for AMI occurred
between 1998 and 2008. The increase in revascularization procedures could explain the decrease in in-hospital
mortality rates.
Keywords: Acute myocardial infarction, Coronary revascularization, Epidemiology, Switzerland, Trends, Drug-eluting
stent, Coronary artery bypass graft, Hospital dischargeBackground
Cardiovascular Diseases (CVD) remain one of the major
causes of deaths worldwide. Switzerland has one of the
lowest CVD mortality rates within Europe [1] with a
sustained downward trend over the last decades [2]. Acute
myocardial infarction (AMI) can be treated with various
drug therapies and revascularization interventions. Indeed,
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reproduction in any medium, provided the orinterventions, has evolved over the last decades [3-8], fol-
lowing the continuously renewed guidelines [9,10].
There are few data on the evolution of AMI manage-
ment and outcome in Switzerland. A study published in
2006 [8] based on data from 68 medical centers participa-
ting in the AMIS Plus register (http://www.amis-plus.ch/
Project.htm) assessed Swiss trends in invasive treatment
and outcome for the period 1997 to 2005. Still, it is un-
known if the findings from this study also apply to non
participating centers, and whether these trends are equally
applied in all Swiss regions. Indeed, in Switzerland, health
policies rarely go down to clinical guidelines and, if theytd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 Characteristics of patients discharged from
hospital with a main diagnosis of acute myocardial
infarction, Switzerland, for period 1998–2008
Year Number of discharges Women (%) Age (years) Rate §
1998 5,530 31.8 66.5 ± 13.9 98.2
1999 6,731 31.4 66.9 ± 13.7 118.8
2000 7,462 31.4 67.2 ± 13.6 130.7
2001 8,235 32.4 67.0 ± 14.0 142.5
2002 9,004 31.3 67.0 ± 14.0 154.2
2003 8,987 31.2 67.2 ± 14.2 152.5
2004 9,251 30.8 66.8 ± 14.1 155.5
2005 9,804 30.3 67.3 ± 14.0 163.5
2006 11,521 29.2 66.9 ± 13.9 190.3
2007 12,370 29.9 67.3 ± 13.9 201.4
2008 13,834 31.3 67.6 ± 13.8 221.3
Results are expressed as percentage or as mean ± standard deviation. Trends
assessed by Cochran-Armitage test or linear regression: p < 0.001 for gender
and age. § defined as the ratio between the number of discharges and the
adult (≥18 years) population, expressed per 100,000 inhabitants.
Figure 1 Number of patients discharged with a main diagnosis of acu
(in-house), in Switzerland and by region, 1998–2008.
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little or no intervention from the federal bodies. The pur-
pose of this study was to assess the trends in AMI man-
agement and outcome for the whole country and for the
main administrative regions, using data from the Swiss
hospital discharge database for the period 1998–2008.
Methods
Databases and available data
Data from the hospital discharge database for years 1998
to 2008 was used. The database was provided by the Swiss
federal office of statistics (www.bfs.admin.ch) and covers
99% of public and private hospitals within Switzerland
[11]. Data providing is compulsory and the information
collected includes gender, age, length of stay, discharge
status (main and secondary diagnoses, vital status) and
procedures. Four types of stays could be obtained: “pass-
ing through”, patients who were admitted from another
hospital and transferred to another hospital; “inbound”,
patients who were admitted from another hospital and
managed on-site; “outbound”, patients who were managed
on-site and transferred to another hospital and “in-house”,
patients who were admitted and managed without being
transferred to another hospital.te myocardial infarction who were managed in a single hospital
Figure 2 Number of patients with a main diagnosis of acute myocardial infarction who were admitted from another hospital and
managed on-site (inbound), in Switzerland and by region, 1998–2008.
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of stay in an intensive care unit (ICU) in hours. When
the length of stay in the ICU was zero, it was considered
as no stay in ICU. Vital status at discharge was indicated
as dead or alive. Overall and seven-day in-hospital all-
cause mortalities were computed; for seven-day morta-
lity, patients who died after seven days were considered
as being alive.
Main and secondary diagnoses at discharge were coded
using the International Classification of Diseases, 10th re-
vision (ICD10) of the World Health Organization. Acute
myocardial infarction was defined as ICD10 code I21X,
where X = any number. The ICD10 coding does not
distinguish between STEMI and non-STEMI. Procedures
were coded using the International Classification of
Diseases, 9th Revision, Clinical Modification (ICD9-CM).
The following revascularization procedures (and corre-
sponding IDC9-CM codes) were assessed: any percutan-
eous coronary intervention (360X); bare (non-drug-eluting)
stent (3606); drug-eluting stent (DES: 3607); coronary ar-
tery bypass grafting (CABG: 361X, 362X and 363X); circu-
latory assistance (376X and 369X) and thrombolysis (3602,3604 and 991); and 379X for other procedures. All these
procedures were coded as binary (yes/no) variables.
Inclusion criteria were: 1) Acute myocardial infarction
(ICD10 code I21X) as the main discharge diagnosis and
2) age ≥18 years. Exclusion criterion was cardiovascular
rehabilitation (ICD9-CM code Z500). Subsequent myo-
cardial infarction (ICD10 code I22), was also excluded, as
it was not possible to trace back to the initial event (and
corresponding management) due to the anonymization
of the data.
Population statistics by age were also obtained from
the Swiss federal office of statistics and used to calculate
a discharge rate, expressed as the number of discharges
per 100,000 adult (≥18 years) inhabitants.
Statistical analysis
Statistical analysis was conducted using SAS software ver-
sion 9.2 (SAS Inc., Cary, NC, USA). Results were expressed
as average ± standard deviation and as number of subjects
and (percentage). Two sets of analyses were performed:
the main analysis for trends in revascularization
Figure 3 Number of patients with a main diagnosis of acute myocardial infarction who were managed on-site and transferred to
another hospital (outbound), in Switzerland and by region, 1998–2008.
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tary analysis was carried out to limit the impact of trans-
fers on significance levels and included only patients who
were treated in one hospital (in-hospital).
Trends in the annual use of revascularisation proce-
dures were assessed by Cochran-Armitage test for trend
and further confirmed by multivariate logistic regres-
sion adjusting for age, gender and type of transfer; when
assessing trends for Switzerland, a further adjustment
was performed on region. Trends for seven-day and
overall mortality rates were assessed among inbound
and in-house patients only, as among “passing through”
and outbound patients mortality was zero. Multivariate
models assessing trends for seven-day and overall hos-
pital mortality rates were adjusted for age, gender, ICU
stay (yes/no), hemodynamic assistance (yes/no) and re-
vascularization procedures (yes/no code: bare stent,
drug eluting stent and CABG); when assessing trends
for Switzerland, a further adjustment was performed on
region. Results were expressed as Odds ratio (OR) and
(95% confidence interval). Statistical significance was
assessed for p < 0.05.Results
Characteristics of the patients
Overall, data from 102,729 hospital discharges from
AMI were analyzed. The characteristics of the patients
discharged according to year are summarized in Table 1.
The percentage of women tended to decrease, while the
mean age of patients at discharge increased by one year.
Discharge rates more than duplicated, from 98.2/100,000
inhabitants in 1998 to 221.3 in 2008 (Table 1).
The number of discharges from AMI rose considerably
from 5530 in 1998 to 13,834 in 2008 (Figures 1, 2, 3 and
4). Most of this increase was due to between-hospital
transfers (inbound, outbound and passing through,
Figures 2, 3 and 4), which increased from 24% in 1998
to 47% in 2008 (for Switzerland). In 2008, over half of
hospital discharges for AMI were due to transfers in
Mittelland (52%) and Ticino (68%).
Intensive care unit
The percentage of hospitalizations with a stay in an
Intensive Care Unit decreased from 38.0% in 1998 to
36.2% in 2008 (p for trend < 0.001, Figure 5). This trend
Figure 4 Number of patients with a main diagnosis of acute myocardial admitted from another hospital and transferred to another
hospital (passing through), in Switzerland and by region, 1998–2008.
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Switzerland. Differing trends were found according to
the region considered: increase in Leman, Eastern and
Central Switzerland; decrease in Northwest, Zurich and
Ticino and no change in Mittelland (Table 2). Restricting
the analysis to patients managed in a single hospital led to
similar results (Additional file 1: Figure S1).
Revascularisation procedures
Percutaneous revascularizations increased sevenfold,
from 6.0% of all patients discharged with AMI in 1998
to 42.4% in 2006, with a slight decrease to 39.9% in 2008
(p for trend < 0.001, Figure 6). This trend was further
confirmed after multivariate adjustment for Switzerland
and all regions considered (Table 2).
Bare (non-drug-eluting) stents rose from 1.3% in 1998
to peak at 21.1% in 2003, further decreasing to 16.6% in
2008 (p for trend < 0.001, Figure 6). This trend was further
confirmed after multivariate adjustment for Switzerland
and all Swiss regions considered (Table 2).
DES appeared in 2004 and steadily peaked at 24.3% in
2006, with a slight decrease to 23.5% in 2008 (p for trend
< 0.001, Figure 6). This trend was further confirmed aftermultivariate adjustment for Switzerland and all regions
concerned, although stronger for Central, Ticino, Eastern
and Zurich than for Leman, Mittelland or Northwest
(Table 2). Restricting the analysis to patients managed in
a single hospital led to similar results (Additional file 2:
Figure S2).
CABG increased from 1.0% in 1998 to peak at 3.3% in
2006, further decreasing to 3.0% in 2008 (p for trend <
0.001, Figure 7). This trend was further confirmed after
multivariate adjustment for Switzerland and all Swiss re-
gions, with the exception of Ticino (Table 2). Restricting
the analysis to patients managed in a single hospital led
to similar results (Additional file 3: Figure S3).
Circulatory assistance increased from 0.24% in 1998 to
2.00% in 2007 and decreased to 1.71% in 2008 (p for
trend < 0.001). This trend was further confirmed after
multivariate adjustment for Switzerland and all Swiss re-
gions, with the exception of Ticino (Table 2).
Finally, no significant trends were found for thromboly-
sis, which increased from 0.5% in 1998 to 6.0% in 2002
and decreased to 1.9% in 2008 (p for trend = 0.09). This
trend was further confirmed after multivariate adjustment
for Switzerland. Conversely, differing trends were found
Figure 5 Trends in intensive care unit (ICU) utilization for acute myocardial infarction in Switzerland, overall and by region, for the
period 1998–2008. Results are expressed as percentage of hospital discharges with a diagnosis of acute myocardial infarction.
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Zurich and Eastern Switzerland, decrease in Northwest
and Ticino and no change in Mittelland and Central
Switzerland (Table 2).
In-hospital mortality
Among patients not transferred to another hospital,
seven-day in-hospital mortality decreased from 8.0% in
1998 to 7.0% in 2008 (p for trend < 0.01, Figure 8), while
total hospital mortality decreased from 11.2% in 1998 to
10.1% in 2008 (p for trend < 0.01, Figure 9). After mul-
tivariate adjustment on age, gender, ICU and revasculari-
zation procedures, no change in seven-day in-hospital
mortality was found for Switzerland and all Swiss regions
(Table 2). Restricting the analysis to patients managed in a
single hospital led to similar results, with the exception
of an increase in mortality in Mittelland and Central
Switzerland (Table 2 and Additional file 4: Figure S4).
For overall in-hospital death, no significant trend was
found for Switzerland, while differing trends were found
for regions: decrease in Eastern; increase in Mittelland
and Central and no change in Leman, Northwest, Zurichand Ticino (Table 2). Restricting the analysis to patients
managed in a single hospital led to similar results, except
that the decrease in Eastern Switzerland was no longer
statistically significant (Table 2).
Discussion
Since the end of the MONICA study [12,13], few studies
have assessed the management and outcome of AMI in
Switzerland. Our results show an increase in most revas-
cularization procedures, namely PCI, while CABG tended
to stabilize or even to decrease in the most recent years.
Moreover, these trends strongly differ according to region.
Overall, the changes in revascularization procedure in
Switzerland follow the ones observed in other countries,
[6,7,14,15]. These findings are also in agreement with a
previous study conducted on 19,500 patients of the AMIS
Plus registry [8], although the increase in PCI procedures
observed [16] was considerably stronger than in ours. This
difference is most likely due to the overrepresentation of
PCI procedures among the AMIS Plus registry hospitals
as the Registry includes only selected voluntary teams.
Table 2 Multivariate analysis of the trends in revascularisation procedures and in in-hospital mortality for patients discharged from hospital with a main
diagnosis of acute myocardial infarction, Switzerland and Swiss regions, for period 1998–2008
Switzerland Leman Mittelland Northwest Zurich Eastern Central Ticino
Revascularization procedures
Number of discharges, all 102,729 18,702 21,275 19,492 17,684 12,522 6,408 6,646
ICU 0.99 (0.98–1.00) 1.06 (1.05–1.07) 0.99 (0.98–1.01) 0.94 (0.93–0.95) 0.92 (0.91–0.93) 1.10 (1.08–1.11) 1.10 (1.08–1.12) 0.85 (0.83–0.87)
Angioplasty 1.25 (1.24–1.25) 1.20 (1.19–1.21) 1.27 (1.25–1.28) 1.26 (1.24–1.27) 1.21 (1.19–1.22) 1.60 (1.55–1.64) 1.80 (1.72–1.89) 1.10 (1.08–1.12)
Bare stent 1.11 (1.10–1.12) 1.14 (1.13–1.15) 1.08 (1.06–1.10) 1.06 (1.04–1.08) 1.07 (1.06–1.08) 1.31 (1.26–1.36) 1.62 (1.54–1.69) 1.05 (1.02–1.07)
Drug-eluting stent 1.66 (1.65–1.68) 1.59 (1.55–1.64) 1.54 (1.51–1.58) 1.52 (1.49–1.56) 1.96 (1.88–2.03) 2.14 (2.03–2.26) 2.97 (2.54–3.46) 2.58 (2.38–2.80)
CABG 1.08 (1.06–1.09) 1.06 (1.03–1.09) 1.19 (1.15–1.23) 1.07 (1.03–1.10) 1.03 (1.00–1.06) 1.71 (1.25–2.33) DNC 1.02 (0.98–1.06)
Circulatory assistance 1.17 (1.14–1.19) 1.10 (1.06–1.14) 1.27 (1.20–1.35) 1.24 (1.15–1.33) 1.13 (1.10–1.17) 2.09 (1.59–2.74) 1.92 (1.45–2.54) 1.02 (0.88–1.19)
Thrombolysis 1.00 (0.99–1.02) 1.02 (1.00–1.05) 0.99 (0.97–1.02) 0.92 (0.88–0.95) 1.06 (1.03–1.08) 1.09 (1.04–1.14) 0.96 (0.90–1.02) 0.91 (0.87–0.95)
In-hospital mortality
Number of discharges § 73,764 13,301 13,905 14,143 13,338 10,132 4,826 4,119
Seven-day mortality 1.00 (0.99–1.01) 1.00 (0.98–1.02) 1.02 (1.00–1.04) 0.99 (0.97–1.01) 0.99 (0.97–1.01) 0.99 (0.96–1.01) 1.03 (0.99–1.06) 1.02 (0.98–1.06)
Overall mortality 1.00 (0.99–1.01) 1.00 (0.98–1.02) 1.02 (1.00–1.04) 1.00 (0.98–1.02) 0.99 (0.97–1.01) 0.98 (0.96–0.99) 1.03 (1.00–1.06) 1.02 (0.99–1.06)
Number of discharges §§ 62,021 11,417 11,371 11,853 11,798 8756 4152 2674
Seven-day mortality 1.01 (1.00–1.02) 1.00 (0.98–1.03) 1.03 (1.01–1.05) 1.00 (0.97–1.02) 1.00 (0.98–1.02) 0.99 (0.97–1.02) 1.05 (1.01–1.09) DNC
Overall mortality 1.01 (1.00–1.02) 1.01 (0.99–1.03) 1.03 (1.01–1.05) 1.01 (0.99–1.03) 1.00 (0.98–1.01) 0.99 (0.96–1.01) 1.04 (1.01–1.08) 1.03 (0.99–1.07)
Results are expressed as multivariate adjusted Odds ratio and (95% confidence interval) for a one-year increase. ICU intensive care unit; CABG coronary artery bypass graft; DNC model did not converge. Statistical
analysis by multivariate logistic regression. For revascularization procedures, analysis was conducted adjusting for age (continuous), gender and transfer type (in-house, inbound, outbound and passing through) for
each Swiss region; for Switzerland, a further adjustment was performed on region. For in-hospital mortality, analysis was conducted adjusting for age (continuous), gender, ICU stay (yes/no), hemodynamic assistance
(yes/no) and revascularization procedures (yes/no code: bare stent, drug eluting stent and CABG) for each Swiss region; for Switzerland, a further adjustment was performed on region. §, patients not transferred to
another hospital (inboud or in-house); §§, patients managed in a single hospital (in-house).
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Figure 6 Trends in the use of drug-eluting and non-drug-eluting stents for acute myocardial infarction in Switzerland, overall and by
region, for the period 1998–2008. Results are expressed as percentage of hospital discharges with a diagnosis of acute myocardial infarction.
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http://www.biomedcentral.com/1471-2458/13/270Between 1998 and 2008, the number of hospital dis-
charges for AMI increased over two-fold in Switzerland.
This finding is in contradiction with some previous studies
[17,18], but it should be noted that these studies showed
declining rates of AMI rather than number of discharges.
Part of this increase might be due to population aging [2],
although the observed increase in population age (from
66.5 years in 1998 to 67.6 years in 2008) would not lead to
a doubling of the number of hospitalizations for AMI.
Further, all analyses were adjusted for age. Another possi-
bility would be a change in disease coding, but again this
is unlikely as hospital discharge data has been shown to be
reliable regarding the diagnosis of AMI [19] and as this
study focused on a specific code. It is also possible that
more people are hospitalized for a second or even a third
AMI (partly related to the decrease in case fatality rate
of the first AMI, leading to an increased incidence of 2nd
or 3rd AMI). Another possibility is the change in criteria
defining AMI [20], which has been shown to increase the
incidence of AMI [21]. The most likely explanation for the
considerable increase in the number of hospital discharges
for AMI in Switzerland is the steep rise in hospitaltransfers, which accounted for almost half of hospital dis-
charges for AMI in 2008. The increase in hospital transfers
might be due to the limited number of hospitals capable
of performing revascularization procedures, prompting
smaller hospitals to transfer their patients as recommended
by European guidelines [22,23]. Still, considerable differ-
ences in the percentages of hospital discharges due to
transfers were noted: in 2008 the values ranged from 40%
in Leman to 68% in Ticino. These differences might be due
to local policies. As AMI management is expensive [24],
the increase in hospital discharges for AMI would add a
considerable pressure in Swiss health expenditures, which
already increased from 9.6% in 1995 to 11.4% of the Swiss
GNP in 2009 [25].
Intensive care unit
The percentage of hospitalizations with ICU stay re-
mained stable between 1998 and 2008 in Switzerland.
This stabilization might be the consequence of im-
proved management, requiring less ICU admissions
before or after a revascularization intervention. Another
likely explanation is the increasing number of transfers,
Figure 7 Trends in the use of coronary artery bypass graft (CABG) for acute myocardial infarction in Switzerland, overall and by
region, for the period 1998–2008. Results are expressed as percentage of hospital discharges with a diagnosis of acute myocardial infarction.
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another hospital for revascularization. Still, considerable
differences in the proportion of hospitalizations with ICU
and corresponding trends were found between regions,
suggesting that other factors such as the number of
ICU beds available or local options for AMI management
might be at play. Unfortunately there is no available infor-
mation regarding the number of ICU beds in each region,
so the precise reasons for the regional differences in ICU
admissions for AMI remain to be further assessed.
Revascularisation procedures
Stent use increased steeply from slightly over 1% in 1998
to nearly 40% in 2008, a finding in agreement with the lit-
erature [26]. DES appeared in 2004 and rose steadily until
2006, when several reports questioning their costs [27,28]
and long term complications [29,30] were published.
These reports slowed down DES use, but some Swiss re-
gions were more responsive than others. For instance, in
the Leman area DES use equaled but never exceeded bare
stent use, while in South Switzerland (Ticino) DES repre-
sented nearly all stents implanted since 2005. The reasonsfor such regional differences are more likely due to local
preferences or to local agreements regarding DES cost
than to decisions based on scientific evidence.
The rate of CABG remained stable at 3% throughout the
study period, a finding also reported in other countries
[3,6]. As for stents, very different trends according to
the region were found. For instance, South Switzerland
(Ticino) showed a steep rise in CABG use, starting in 1999
to reach an average rate of 7%, well above the Swiss aver-
age. This trend might partly be explained by the creation
in 1999 of new medical centers with the capacity to carry
out these interventions. Conversely, in Eastern and Central
Switzerland, hardly any CABG was performed until 2007,
likely the result of the lack of required infrastructure. Over-
all, our results show that CABG rates evolved differently
between Swiss regions, the most likely explanations being
the existence of infrastructures and local preferences for
certain types of revascularization procedures.
In-hospital mortality
An overall decrease in seven-day in-hospital mortality was
found for Switzerland, a finding also reported elsewhere
Figure 8 Trends in seven-day in-hospital mortality rates from acute myocardial infarction in Switzerland, overall and by region, for the
period 1998–2008. Results are expressed as percentage of patients inbound or in-house discharged with a diagnosis of acute myocardial
infarction.
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http://www.biomedcentral.com/1471-2458/13/270[8,16]. This trend was no longer significant after multivari-
ate adjustment, suggesting that most of the decrease in
mortality is due to revascularization interventions and the
improved quality of treatment according to the newest
guidelines [9,10]. Restricting the analysis to patients who
survived at least three days led to similar findings, al-
though some regions presented a slight increase in mor-
tality (Additional file 5: Table S1). The rising prevalence of
CV risk factors in Switzerland [31] could also contribute
to lessen the decrease in AMI mortality [32], but it was
not possible to adequately consider them in the multivari-
ate model as they are not reported systematically in the
database. Similarly, it was not possible to assess whether
the patients presented with a STEMI or a non-STEMI,
and which drug treatments were provided during hospital
stay, all factors associated with in-hospital mortality
[22,23,33]. Overall, our data suggest that the increasing
number of revascularization interventions performed
among patients discharged with a main diagnosis of
AMI do not suffice to decrease in-hospital mortality
in Switzerland, a country presenting the lowest CVDmortality within Europe [1]. Further studies are mandatory
to better assess the factors associated with in-hospital mor-
tality from AMI in order to optimize patient management.
Study limitations
This study has some limitations. Medicines are not in-
cluded in the hospital discharge database, thus preclud-
ing the assessment of their trends. This absence might
also explain the very low rates for thrombolysis, which
are likely due to the absence of coding rather than a true
absence of use. Furthermore, we lack data to assess
whether the changes in thrombolytic therapy are related
to changes in reporting levels or are actually real
changes. The ICD10 coding does not distinguish STEMI
from NSTEMI; hence, it is possible that part of the in-
crease in discharges from AMI during the study period
might be related to the change in the definition of
NSTEMI populations due to the generalization of the
use of troponin measurements. Indeed, introduction of
troponin measurements led to the reclassification of
many unstable angina patients into NSTEMI patients,
Figure 9 Trends in overall in-hospital mortality rates from acute myocardial infarction in Switzerland, overall and by region, for the
period 1998–2008. Results are expressed as percentage of patients inbound or in-house discharged with a diagnosis of acute myocardial
infarction.
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before to after the introduction of troponin measure-
ments [34]. Still, including unstable angina (ICD10 code
I200) in the analysis led to similar findings, with the ex-
ception that the increase in CABG was no longer signifi-
cant and even decreased in some regions (Additional file
5: Table S1). The strong increase in the number of
between-hospital transfers and the anonymization of the
data (which precluded the follow-up of the patients)
complicated the interpretation of the trends. Still,
restricting the analysis to patients fully managed in a sin-
gle hospital led to similar results. It was not possible to as-
sess “true” seven- and 30-day mortality rates as no follow-
up data was available for the patients discharged. The
AMIS registry, which collects vital status data for AMI pa-
tients hospitalized in the participating institutions, will be
able to provide such information [35]. Finally, there is no
published information on the validity of hospital discharge
data in Switzerland regarding the diagnosis of AMI. Still,
using the results from an ongoing study (CoLaus), of 159
hospitalizations for AMI, 145 (91%) were confirmed assuch by an independent panel of cardiologists, a value in
agreement with the literature [36,37].
Conclusion
In Switzerland, a steep rise in hospital discharges and in
revascularization procedures for AMI occurred between
1998 and 2008.
Additional files
Additional file 1: Figure S1. Trends in intensive care unit (ICU)
utilization for acute myocardial infarction in Switzerland, overall and by
region, for the period 1998–2008, patients managed in a single hospital
(in-house). Results are expressed as percentage of patients discharged
with a diagnosis of acute myocardial infarction.
Additional file 2: Figure S2. Trends in the use of drug-eluting and
non-drug-eluting stents for acute myocardial infarction in Switzerland,
overall and by region, for the period 1998–2008, patients managed in a
single hospital (in-house). Results are expressed as percentage of patients
discharged with a diagnosis of acute myocardial infarction.
Additional file 3: Figure S3. Trends in the use of coronary artery
bypass graft (CABG) for acute myocardial infarction in Switzerland, overall
and by region, for the period 1998–2008, patients managed in a single
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Additional file 4: Figure S4. Trends in seven-day in-hospital mortality
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region, for the period 1998–2008, patients managed in a single hospital
(in-house). Results are expressed as percentage of patients discharged
with a diagnosis of acute myocardial infarction.
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